Genmab A/S (GMAB) has a market capitalization of $17.94B and trades at $29.06. The 52-week range is 17.235-35.43.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 18.7, Earnings Per Share (EPS) of $1.55, annual revenue of $3.72B.
The stock has a beta of 0.74, operates in the Healthcare sector.
